⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15143 | 0.72 | — | — | |
| SCHEMBL5419242 | 0.72 | — | — | |
| SCHEMBL137063 | 0.72 | — | — | |
| SCHEMBL5411439 | 0.72 | — | — | |
| SCHEMBL5573210 | 0.72 | — | — | |
| SCHEMBL4758979 | 0.72 | — | — | |
| SCHEMBL23451785 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL9537 | 0.67 | — | — | |
| SCHEMBL11030471 | 0.67 | — | — | |
| Trimethylammonium SCHEMBL10776563 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045841-B1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | CHOONGWAE PHARMA CORP (KR) | 2002-12-04 | — | — | EP | claimed |
| US-6262083-B1 | Genipin derivative having liver protection activity | CHOONGWAE PHARMA CORPORATION (KR) | 2001-07-17 | — | — | US | claimed |
| EP-1045841-A1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | Choongwae Pharma Corporation (KR) | 2000-10-25 | — | — | EP | claimed |
| WO-1999023090-A1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | CHOONGWAE PHARMA CORPORATION (KR) | 1999-05-14 | — | — | WO | claimed |
| US-5563165-A | PROSTAGLANDIN INHIBITOR; FDA ORANGE BOOK LISTED PATENT FOR CELEBREX | G. D. SEARL & CO. (US) | 1996-10-08 | — | — | US | claimed |
| US-5510496-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | claimed |
| CN-1532293-B | Nucleic acid fixing method and method for producing biosensor by said method | SEIKO EPSON CORP | 2011-05-11 | — | — | CN | disclosed |
| CN-1532293-A | Nuclein acid fixing method and method for producing biosensor by said method | ������������ʽ���� | 2004-09-29 | — | — | CN | disclosed |
| EP-1045841-B1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | CHOONGWAE PHARMA CORP (KR) | 2002-12-04 | — | — | EP | disclosed |
| US-6262083-B1 | Genipin derivative having liver protection activity | CHOONGWAE PHARMA CORPORATION (KR) | 2001-07-17 | — | — | US | disclosed |
| EP-1045841-A1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | Choongwae Pharma Corporation (KR) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999023090-A1 | NOVEL GENIPIN DERIVATIVE HAVING LIVER PROTECTION ACTIVITY | CHOONGWAE PHARMA CORPORATION (KR) | 1999-05-14 | — | — | WO | disclosed |
| US-5753688-A | ANTIINFLAMMATORY | TALLEY JOHN J (US) | 1998-05-19 | — | — | US | disclosed |
| US-5563165-A | PROSTAGLANDIN INHIBITOR; FDA ORANGE BOOK LISTED PATENT FOR CELEBREX | G. D. SEARL & CO. (US) | 1996-10-08 | — | — | US | disclosed |
| US-5521207-A | Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation | G.D. SEARLE & CO. (US) | 1996-05-28 | — | — | US | disclosed |
| US-5516907-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5510496-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5508426-A | ANTIARTHRITIC AGENT | G. D. SEARLE & CO. (US) | 1996-04-16 | — | — | US | disclosed |
| US-5504215-A | Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-04-02 | — | — | US | disclosed |
| US-5466823-A | Antiinflammatory agents; FDA Orange book listed patent for Celebrex | G.D. SEARLE & CO. (US) | 1995-11-14 | — | — | US | disclosed |